GORX Geopharma (MM)

GeoPharma Inc. (Nasdaq: GORX) announces the following Webcast: What: � Fiscal Year 2009 First Quarter Earnings Release and Conference Call Earnings will be released after the close on 8/14/08 Conference Call to follow. � When: August 14, 2008 @ 4:35 PM Eastern � Where: http://www.investorcalendar.com/ClientPage.asp?ID=132430 � How: Live over the Internet � Simply log on to the web at the address above. Live Dial-in (Toll Free): 877-407-8031 International Dial-in: 201-689-8031 Teleconference Replay Available Until: August 28, 2008 @ 11:59 PM Replay Number (Toll Free): 877-660-6853 Replay Number (International): 201-612-7415 Replay Pass codes (both required for playback): Account #: 286 Conference ID #: 292766 � For additional information, contact: Alexander Nachman, 727-471-0871, ext. 243 E-mail: ir@geopharmainc.com If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=132430 or http://www.investorcalendar.com GeoPharma, Inc. is a rapidly growing Bio/Pharma company with a diversified business model participating in 3 main market segments: Specialty Pharma, Manufacturing, and Distribution. The Specialty Pharma division specializes in the formulation of generic drugs for human and veterinary usage and the development of medical devices used by oncologists and other medical professionals. The Manufacturing and Distribution divisions, manufacture, package, and distribute generic drugs, nutraceuticals, cosmetics, and functional food products for companies worldwide. GeoPharma's growth strategy is to capitalize on its research and manufacturing expertise to develop medical devices and high margin generic drug products for niche markets with high barriers to entry. GeoPharma's competitive advantage in these areas is in its ability to navigate the challenges that such market pursuits present effectively. Currently GeoPharma employs over 300 people and operates facilities in Florida, Maryland, Pennsylvania, Nevada, Rhode Island, and Texas utilizing over 330,000 sq. ft. of office, warehouse, manufacturing and laboratory facilities. For further information visit the "For Investors" section of the GeoPharma website at www.geopharmainc.com.